DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a fast-growing innovator in point-of-care ocular diagnostics, today announced highly encouraging interim results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback